F3-01-03: Disclosure of amyloid status in secondary prevention trials for Alzheimer's disease

Frequencies of HLA-E*01:01/*01:03 Alleles in an Iranian Healthy Population and Its Comparison with Hyperglycemia Patients

Background and Aims: The human leukocyte antigen-E (HLA-E) is a member of non-classical HLA class-I genes which is highly conserved through evolution. In general, so far 25 alleles of HLA-E have been described. However, the existence of only two allelic group; HLA-E*01:01 and HLA-E*01:03 have been demonstrated in all the populations. HLA-E*01:01 and HLA-E*01:03 differ only at codon 107 of exon ...

Secondary prevention antibiotic treatment trials for coronary artery disease.

Considerable interest was generated in the possible causative role of Chlamydia pneumoniae in coronary artery disease (CAD) by the publication of a small pilot study in London of antibiotic treatment of CAD that reduced coronary events.1 Persons familiar with antibiotic treatment of chlamydia were skeptical that the brief treatment schedule in the London trial (azithromycin either one or two co...

Primary and secondary prevention trials in coronary heart disease.

Alzheimers Disease: A Novel Hypothesis for the Development and the Subsequent Role of Beta Amyloid

Spirochetes, biofilms, and innate immune system activity have all been recently found in the brains of Alzheimer’s disease patients. The mechanism and actions of those factors in producing the disease were discussed in those studies. However, neither the production nor the role of beta amyloid was included in the discussion of those studies. In this commentary, we hypothesize how the developmen...

on the status of mixed methods research in applied linguistics

چکیده ندارد.